Novavax vaccine now available

July 20, 2022
Covid-19 vaccine bottles

For those waiting for a COVID-19 vaccine built on a different technology, now is the time to get vaccinated.

Dr. Rochelle Walensky, director of the CDC, in a tweet announcing the official go-ahead for the Novavax vaccine in the U.S.
  • Why It Matters: The Centers for Disease Control and Prevention (CDC) officially recommended the Novavax vaccine for adults ages 18 and up, making it the fourth COVID vaccine available in the U.S.
  • What sets this vaccine apart from others: "Novavax’s protein-based vaccine uses a relatively older and more tested technology that serves as the backbone of vaccines for hepatitis B and the human papillomavirus, or HPV" (Wall Street Journal). The vaccine is already available in Europe and other countries such as Canada and Australia.
  • CDC advisers unanimously endorsed the vaccine, which is recommended as a two-dose series given at least three weeks apart. However, several advisers noted that regulators still need to approve a booster option from Novavax that can be given "five or so months" after initial vaccination (AP).
  • State of the pandemic: Overall, COVID-19 cases have risen in recent weeks in 40 states; rates of hospitalizations due to COVID have also risen. Health officials attribute this to the circulation of a more transmissible variant (though it hasn't been shown to cause more severe disease).

CDC endorses more traditional Novavax COVID shot for adults (Associated Press)

Dr. Rochelle Walensky's tweet

For more about the Novavax vaccine timeline and efficacy (SmartHer News)

by Jenna Lee,